Dr Emma Kampouraki
Dr Peter Avery
Dr Tina Biss
Dr Hilary Wynne
Professor Farhad Kamali
et al. | Assessment of exposure to direct oral anticoagulants in elderly hospitalised patients | 2021 |
|
Dr Emma Kampouraki
Dr Salah Abohelaika
Dr Peter Avery
Dr Tina Biss
Dr Hilary Wynne
et al. | Elderly people are inherently sensitive to the pharmacological activity of rivaroxaban: implications for DOAC prescribing | 2021 |
|
Dr Alison Bray
Dr Emma Kampouraki
Amanda Winter
Dr Peter Messer
Dr Sara Graziadio
et al. | High variability in sepsis guidelines in UK: Why does it matter? | 2020 |
|
Dr Paul Ayuk
Dr Emma Kampouraki
Frances Sidgwick
Professor Farhad Kamali
| Investigation of dabigatran secretion into breast milk: Implications for oral thromboprophylaxis in post-partum women | 2019 |
|
Dr Emma Kampouraki
Professor Farhad Kamali
| Pharmacogenetics of anticoagulants used for stroke prevention in patients with atrial fibrillation | 2019 |
|
Dr Salah Abohelaika
Dr Hilary Wynne
Dr Peter Avery
Dr Emma Kampouraki
Professor Farhad Kamali
et al. | Effect of genetic and patient factors on warfarin pharmacodynamics following warfarin withdrawal: Implications for patients undergoing surgery | 2018 |
|
Dr Emma Kampouraki
Dr Peter Avery
Dr Hilary Wynne
Dr Tina Biss
Dr John Hanley
et al. | Assessment of the efficacy of a novel tailored vitamin K dosing regimen in lowering the International Normalised Ratio in over-anticoagulated patients: A randomised clinical trial | 2017 |
|
Dr Emma Kampouraki
Dr Peter Avery
Dr Tina Biss
Professor Farhad Kamali
| Association between CYP4F2 genotype and circulating plasma vitamin K concentration in children on chronic warfarin therapy: Possible long-term implications for bone development and vascular health | 2017 |
|
Dr Emma Kampouraki
Professor Farhad Kamali
| Dietary implications for patients receiving long-term oral anticoagulation therapy for treatment and prevention of thromboembolic disease | 2017 |
|
